Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety

Biochem Biophys Res Commun. 2005 Jun 3;331(2):571-6. doi: 10.1016/j.bbrc.2005.04.007.

Abstract

Botulism is a highly fatal disease caused by the botulinum progenitor toxin. In this study, the role of oligosaccharides for the binding of botulinum type A progenitor toxin (type A PTX) to human intestinal cells was investigated. The binding of type A PTX to Intestine-407 cells was inhibited by the addition of N-acetyllactosamine, lactose, and galactose. Treatment of Intestine-407 cells with neuraminidase led to a significant increase in the binding of type A PTX, while further digestion of cell surface oligosaccharides by beta-galactosidase and beta-N-acetylhexosaminidase decreased the binding. These results indicate that the N-acetyllactosamine moiety is responsible for the binding of type A PTX. These findings were further confirmed by a binding assay using synthesized oligosaccharides. Interestingly, sialylation or fucosylation of oligosaccharides inhibited the binding of type A PTX. These data suggest that the type A PTX binds to intestinal cells via cell surface N-acetyllactosamine moiety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Sugars / chemistry
  • Amino Sugars / metabolism*
  • Botulinum Toxins, Type A / chemistry*
  • Botulinum Toxins, Type A / metabolism*
  • Cell Line
  • Clostridium botulinum*
  • Epithelial Cells / metabolism*
  • Glycoside Hydrolases / metabolism
  • Glycosylation
  • Humans
  • Intestines / cytology*
  • Oligosaccharides / metabolism
  • Oligosaccharides / pharmacology
  • Serum Albumin, Bovine / metabolism

Substances

  • Amino Sugars
  • Oligosaccharides
  • Serum Albumin, Bovine
  • N-acetyllactosamine
  • Glycoside Hydrolases
  • Botulinum Toxins, Type A